Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Halpin

Showing results (101-110 of 197) with videos related to

Pageof 20
Sort By:
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|October 17, 2008
Guidelines versus practice: UK asthma nurses often recommend intermittent, symptom-driven use of inhaled corticosteroidsMichael E Hyland, Sue Blake, Colin J Greaves, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|June 21, 2011
A randomised controlled trial of the effect of automated interactive calling combined with a health risk forecast on frequency and severity of exacerbations of COPD assessed clinically and using EXACT PRODavid M G Halpin, Tish Laing-Morton, Sarah Spedding, et al.
Respiratory Research|July 11, 2020
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trialKlaus F Rabe, David M G Halpin, MeiLan K Han, et al.
Advances in Therapy|April 2, 2023
A Response to: Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis"Afisi S Ismaila, Katrin Haeussler, Mia Malmenäs, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 12, 2025
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UKRui Cai, Alan A Martin, Yuchen Ge, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|November 9, 2019
Home or surgery based screening for chronic obstructive pulmonary disease (COPD)?D A Seamark, S Williams, S Timon, et al.
Respirology (Carlton, Vic.)|February 1, 2026
Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)David M G Halpin, Refiloe Masekela, Claus F Vogelmeier, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2022
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 ReviewDave Singh, Alvar Agusti, Fernando J Martinez, et al.
Thorax|May 17, 2024
Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional studyMarie Stolbrink, Obianuju B Ozoh, David M G Halpin, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2025
Addressing the Global Challenges of COPD and Asthma: A Shared Vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)David M G Halpin, Refiloe Masekela, Claus F Vogelmeier, et al.
Pageof 20

Showing results (101-110 of 197) with videos related to

Sort By:
Pageof 20
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|October 17, 2008
Guidelines versus practice: UK asthma nurses often recommend intermittent, symptom-driven use of inhaled corticosteroidsMichael E Hyland, Sue Blake, Colin J Greaves, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|June 21, 2011
A randomised controlled trial of the effect of automated interactive calling combined with a health risk forecast on frequency and severity of exacerbations of COPD assessed clinically and using EXACT PRODavid M G Halpin, Tish Laing-Morton, Sarah Spedding, et al.
Respiratory Research|July 11, 2020
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trialKlaus F Rabe, David M G Halpin, MeiLan K Han, et al.
Advances in Therapy|April 2, 2023
A Response to: Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis"Afisi S Ismaila, Katrin Haeussler, Mia Malmenäs, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 12, 2025
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UKRui Cai, Alan A Martin, Yuchen Ge, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|November 9, 2019
Home or surgery based screening for chronic obstructive pulmonary disease (COPD)?D A Seamark, S Williams, S Timon, et al.
Respirology (Carlton, Vic.)|February 1, 2026
Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)David M G Halpin, Refiloe Masekela, Claus F Vogelmeier, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2022
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 ReviewDave Singh, Alvar Agusti, Fernando J Martinez, et al.
Thorax|May 17, 2024
Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional studyMarie Stolbrink, Obianuju B Ozoh, David M G Halpin, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2025
Addressing the Global Challenges of COPD and Asthma: A Shared Vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)David M G Halpin, Refiloe Masekela, Claus F Vogelmeier, et al.
Pageof 20